Instrument Inactif

Communiqués PhaseBio Pharmaceuticals, Inc.

Actions

PHAS.Q

US7172241090

Communiqués

31/10/22	PHASEBIO PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
24/10/22	PHASEBIO PHARMACEUTICALS INC : Bankruptcy or Receivership, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
24/10/22	PhaseBio Plans for Near-Term Sale Using Structured Process Through Chapter 11 of U.S. Bankruptcy Code	BU
07/10/22	PHASEBIO PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant (form 8-K)	AQ
27/09/22	PHASEBIO PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
15/08/22	PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights	AQ
12/08/22	PhaseBio Pharmaceuticals : Reports Second Quarter 2022 Financial Results and Recent Business Highlights - Form 8-K	PU
12/08/22	PHASEBIO PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
12/08/22	PHASEBIO PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
12/08/22	PhaseBio Pharmaceuticals Reports Second Quarter 2022 Financial Results and Recent Business Highlights	BU
08/08/22	PHASEBIO PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
05/07/22	PHASEBIO PHARMACEUTICALS INC : Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing (form 8-K)	AQ
20/05/22	PHASEBIO PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
16/05/22	PHASEBIO PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
16/05/22	PHASEBIO PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
16/05/22	PhaseBio Pharmaceuticals Reports First Quarter 2022 Financial Results and Recent Business Highlights	BU
16/05/22	PhaseBio Announces Successful Pre-BLA Meeting with U.S. FDA for Bentracimab	BU
07/04/22	PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference	BU
04/04/22	PhaseBio Pharmaceuticals : Announces Positive Results from Phase 2b Trial for Bentracimab - Form 8-K	PU
04/04/22	PHASEBIO PHARMACEUTICALS INC : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
04/04/22	PhaseBio Announces Positive Results from Phase 2b Trial for Bentracimab	BU
24/03/22	PhaseBio Pharmaceuticals : Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights - Form 8-K	PU
24/03/22	PHASEBIO PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
24/03/22	PHASEBIO PHARMACEUTICALS INC : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
24/03/22	PhaseBio Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Recent Business Highlights	BU